# Novavax to Participate in BofA Securities 2026 Health Care Conference - May 7, 2026
Canonical URL: https://biopharmsignal.com/news/NVAX/novavax-to-participate-in-bofa-securities-2026-health-care-conference-may-7-2026-b9786971
Ticker: NVAX
Company: Novavax
Source: Novavax
Published: 2026-07-09 12:00 EST
Original Source URL: https://ir.novavax.com/press-releases
## Summary

Novavax, Inc. (Nasdaq: NVAX) today announced that it will participate in the BofA Securities 2026 Health Care Conference. Conference Details: Fireside Chat Date: Wednesday, May 13, 2026 Time: 3:00...

## Article Body
GAITHERSBURG, Md. , May 7, 2026 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that it will participate in the BofA Securities 2026 Health Care Conference.

Conference Details:

Fireside Chat

Date:

Wednesday, May 13, 2026

Time:

3:40 – 4:10 p.m. Pacific Time

Location:

Las Vegas, NV

Conference

Event:

Investor Meetings

Date:

Wednesday, May 13, 2026

A webcast of the fireside chat will be available on the Events & Presentations page of the Company's website at ir.novavax.com . A replay of the webcast will be available for 30 days.

About Novavax

Novavax, Inc. tackles some of the world's most pressing health challenges with its scientific expertise in vaccines and its proven technology platform, including its Matrix-M ® adjuvant and protein-based nanoparticles. The Company's corporate growth strategy is designed to deliver value via three key strategic pillars: partnering its technology, capital-efficient research and development (R&D) innovation and a lean and efficient operating model. This includes maximizing impact through partnerships for its marketed products (Nuvaxovid™, R21/Matrix-M™), Matrix technology and R&D assets. Please visit novavax.com and LinkedIn for more information.

Contacts:

Investors

Jim Kelly

844-668-2829 [email protected]

Media

Yvonne Sprow

844-264-8571 [email protected]

SOURCE Novavax, Inc.
## Recent Company News
- 2026-07-09 12:00 EST — [Novavax Reports First Quarter 2026 Financial Results and Operational Highlights - May 6, 2026](https://biopharmsignal.com/news/NVAX/novavax-reports-first-quarter-2026-financial-results-and-operational-highlights--a11612f1) — Source: Novavax
- 2026-07-09 12:00 EST — [Novavax to Participate in BofA Securities 2026 Health Care Conference - May 7, 2026](https://biopharmsignal.com/news/NVAX/novavax-to-participate-in-bofa-securities-2026-health-care-conference-may-7-2026-b9786971) — Source: Novavax
- 2026-07-09 12:00 EST — [Novavax to Participate in 2026 Jefferies Global Healthcare Conference - Jun 1, 2026](https://biopharmsignal.com/news/NVAX/novavax-to-participate-in-2026-jefferies-global-healthcare-conference-jun-1-2026-13dbcea1) — Source: Novavax
## Related News
- 2026-07-21 12:00 EST — MOR — [Novartis delivered sales growth in Q2 and further advanced the pipeline; Full-year guidance reaffirmed](https://biopharmsignal.com/news/MOR/novartis-delivered-sales-growth-in-q2-and-further-advanced-the-pipeline-full-yea-63a32b47)
- 2026-07-20 20:05 EST — RANI — [Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/RANI/rani-therapeutics-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4-ec56b3b0)
- 2026-07-20 14:53 EST — IPHA — [Innate Pharma announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-Drug Conjugate (ADC)](https://biopharmsignal.com/news/IPHA/innate-pharma-announces-completion-of-enrollment-in-phase-1-dose-escalation-stud-0778493f)
- 2026-07-20 13:05 EST — ACAD — [Acadia Pharmaceuticals Receives FDA Fast Track Designation for Remlifanserin in Alzheimer's Disease Psychosis](https://biopharmsignal.com/news/ACAD/acadia-pharmaceuticals-receives-fda-fast-track-designation-for-remlifanserin-in--f36b622c)
- 2026-07-20 13:00 EST — ENLV — [Enlivex Treasury Portfolio Update: NAV Per Ordinary Share $66.16; Total Treasury Holdings Valued at Approximately $1.1 Billion](https://biopharmsignal.com/news/ENLV/enlivex-treasury-portfolio-update-nav-per-ordinary-share-66-16-total-treasury-ho-9d036ef9)